Abiopharma

Clinical trial NCT06880744: completion date: 2028-09-01 → 2027-08-01.

Clinical trial NCT06374212 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-07-15 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07526506: enrollment: 24 → 32 participants.

Clinical trial NCT06659341: completion date: 2027-06-15 → 2027-07-30.

Clinical trial NCT07284745 updates: 1. completion date: 2029-07-05 → 2029-08-06 2. primary completion date: 2029-07-05 → 2029-08-06

Clinical trial NCT07549490: start date: 2026-08-05 → 2026-08-06.

Clinical trial NCT03530852: collaborators added: Food and Drug Administration (FDA).

Clinical trial NCT04447521 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-12-31 → 2025-12-10 3. enrollment: 3600 → 1404 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07506863: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07528508: status: RECRUITING → ACTIVE_NOT_RECRUITING.